510(k) Report

510(k) · Cleared

Recalled · Class II · 2017

Haemonetics Cell Saver 5 Autologous Blood Recovery System

K014083510(k) SpecialCleared Jan 8, 200228-day reviewClass II21 CFR 868.5830Recalls 3

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Haemonetics Corp. · CAC Apparatus, Autotransfusion

Cleared on Jan 8, 2002 as substantially equivalent to K932890 (Haemonetics Corp., 1994) after a 28-day review. Its family tree reaches back 1 generation to 1994. 5 later devices descend from it. It has been recalled 3 times.

Decided
Jan 8, 2002
Review
28 days
Class
Class II
Product code
CAC
Recalls
3
Predicates
1

Its longest line of descent runs back 1 generation to K932890 (1994). 5 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2012: 1 descendant cleared2016: 1 descendant cleared2017: 1 descendant cleared2022: 1 descendant clearedK932890 · Cell Saver 5 System · Haemonetics Corp. · 1994 · recalled1990200020102020
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant3 generations forward: 1 descendant4 generations forward: 1 descendant5 generations forward: 1 descendant K932890 · Cell Saver 5 System · Haemonetics Corp. · 1994 · recalled0+5
  1. Root · 1 generation backK932890 Cell Saver 5 SystemHaemonetics Corp. · 1994 · Recalled
  2. This deviceK014083 Haemonetics Cell Saver 5 Autologous Blood Recovery SystemHaemonetics Corp. · 2002
  3. Descendant · cites it directly · 4 of its ownK101907 Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corp. · 2010 · Recalled
  4. Descendant · 2 generations on · 3 of its ownK120586 Cell Saver EliteHaemonetics Corp. · 2012
  5. Descendant · 3 generations on · 2 of its ownK160197 Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corporation · 2016
  6. Descendant · 4 generations on · 1 of its ownK162423 Haemonetics Cell Saver Elite/Elite+ Autotransfusion SystemHaemonetics Corporation · 2017
  7. Descendant · 5 generations on · 0 of its ownK221722 Haemonetics Cell Saver Elite/Elite+ Autotransfusion System…Haemonetics Corporation · 2022

Most influential descendants

Showing 5 of 5 · See all
  • K101907Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corp. · 2010 · cites it directly4descendants
  • K120586Cell Saver EliteHaemonetics Corp. · 2012 · 2 generations on3descendants
  • K160197Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corporation · 2016 · 3 generations on2descendants
  • K162423Haemonetics Cell Saver Elite/Elite+ Autotransfusion SystemHaemonetics Corporation · 2017 · 4 generations on1descendant
  • K221722Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)Haemonetics Corporation · 2022 · 5 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K932890Cell Saver 5 SystemHaemonetics Corp.199413
0 (this device)K014083Haemonetics Cell Saver 5 Autologous Blood Recovery SystemHaemonetics Corp.2002—
+1K101907Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corp.20106
+2K120586Cell Saver EliteHaemonetics Corp.2012—
+3K160197Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corporation2016—
+4K162423Haemonetics Cell Saver Elite/Elite+ Autotransfusion SystemHaemonetics Corporation2017—
+5K221722Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)Haemonetics Corporation2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201210
201610
201710
202210
FIG. 1 — Lineage of K014083, 1994–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAC device

  1. #1 K240426 Aventus Clot Management Systemscore 11.2 · 4 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K932890Cell Saver 5 System
Summary page 1
…mL bowl) ¢ LN263 Haemonetics Basic High Speed Cell Saver 5 Bowl Set (225mL bowl) List No Predicate Device Reference CS5 with Cell Salvage and CS5 with Cell Salvage and K932890 Sequestration Protocol Sequestration Protocol Software Software Revision K Revision - e LN261 Haemonetics Basic Low e K932890 LN…
Haemonetics Corp.199413
*—LN246 10L Waste Bag
Named without a submission number
—

What descends from it? (5)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K101907Haemonetics Cell Saver Elite Autotransfusion SystemHaemonetics Corp.20104

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 2, 2017Class IIZ-0778-2019Process controlHaemonetics has received isolated reports that in some cases the 70ml centrifuge bowl may leak during cell salvage processing.
Dec 21, 2005Not classifiedZ-0822-06OtherDevice emits radiofrequency which exceed the IEC 60601-1-2 International Standard
Dec 21, 2005Not classifiedZ-0823-06OtherDevice emits radiofrequency which exceed the IEC 60601-1-2 International Standard

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • Of its descendants, K101907 (Haemonetics Corp., 2010) has gone furthest, with 4 descendants of its own.

How does its category compare?

All CAC devices

CAC Apparatus, Autotransfusion: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CAC

3in 2024

2008: 12010: 42011: 22012: 32013: 12014: 32016: 22017: 12018: 22019: 12020: 12021: 42022: 12023: 22024: 3
2007high 4 (2010) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAC

91in 2024

2010: 123 days median2012: 90 days median2014: 269 days median2021: 155 days median2024: 91 days median
2007high 269 (2014) · low 90 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAC

7in 2023

2007: 12008: 52009: 252010: 32011: 32013: 92017: 22018: 22019: 232023: 7, 2 Class I
2007high 25 (2009) · low 0 (2012)2026

Class I (2 since 2007) Class II/III not classified

Adverse event reports per year · CAC

128in 2025

2007: 352008: 122009: 682010: 1152011: 9392012: 2492013: 1532014: 902015: 872016: 732017: 882018: 872019: 642020: 1082021: 732022: 652023: 392024: 1292025: 128
2007high 939 (2011) · low 12 (2008)2025

MAUDE reports naming product code CAC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—135
20081—512
20090—2568
201041233115
20112—3939
20123900249
20131—9153
20143269090
20150—087
20162—073
20171—288
20182—287
20191—2364
20201—0108
20214155073
20221—065
20232—7 (2)39
20243910129
20250—0128
20260—0—

What is it indicated for?

The Cell Saver 5 Autologous Blood Recovery System is intended for use to recover blood shed during or subsequent to an operation or as a result of trauma, processing the blood by a centrifugation and washing procedure, and pumping this processed red cell product to either a bag for gravity reinfusion into the patient or to the arterial line of an extracorporeal circuit for reinfusion into the patient. The intended use of the Sequestration Protocol is to…

Read the full statement (133 words)

The Cell Saver 5 Autologous Blood Recovery System is intended for use to recover blood shed during or subsequent to an operation or as a result of trauma, processing the blood by a centrifugation and washing procedure, and pumping this processed red cell product to either a bag for gravity reinfusion into the patient or to the arterial line of an extracorporeal circuit for reinfusion into the patient. The intended use of the Sequestration Protocol is to collect an autologous, preoperative, platelet rich plasma product for reinfusion to the same patient within 6 hours of collection.

The LN291A is intended to be used with the CS5 Autologous Blood Recovery System for cell salvage protocols.

The LN242 is intended to be used with the CS5 Autologous Blood Recovery System as a replacement waste bag.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K014083: Haemonetics Cell Saver 5 Autologous Blood Recovery System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K014083

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026